P A Jones

Summary

Affiliation: University of Southern California
Country: USA

Publications

  1. ncbi The DNA methylation paradox
    P A Jones
    Department of Biochemistry and Molecular Biology, University of Southern, California Norris Comprehensive Cancer Center and Hospital, Los Angeles 90033 0800, USA
    Trends Genet 15:34-7. 1999
  2. ncbi Cancer epigenetics comes of age
    P A Jones
    Department of Biochemistry and Molecular Biology, University of Southern California School of Medicine, The Norris Comprehensive Cancer Center, Los Angeles 90033, USA
    Nat Genet 21:163-7. 1999
  3. ncbi The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells
    M M Pao
    Department of Biochemistry and Molecular Biology, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA 90089-9176, USA
    Hum Mol Genet 10:903-10. 2001
  4. ncbi Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer
    D Takai
    Department of Biochemistry and Molecular Biology, USC Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, 1441 Eastlake Avenue, Los Angeles, CA 90033, USA
    Hum Mol Genet 10:2619-26. 2001
  5. ncbi The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells
    G Liang
    Department of Biochemistry and Molecular Biology, University of Southern California Norris Comprehensive Cancer Center, School of Medicine, Los Angeles 90033, USA
    Cancer Res 60:4907-12. 2000
  6. ncbi Expression of H19 does not influence the timing of replication of the Igf2/H19 imprinted region
    C Q Windham
    Department of Biochemistry and Molecular Biology, USC Norris Comprehensive Cancer Center, Los Angeles, USA
    Dev Genet 20:29-35. 1997
  7. ncbi Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation
    C T Nguyen
    Department of Biochemistry and Molecular Biology, USC/Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, 1441 Eastlake Avenue, Room 8302L, Los Angeles, CA 90089-9181, USA
    Nucleic Acids Res 29:4598-606. 2001
  8. ncbi Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells
    C Nguyen
    Department of Biochemistry and Molecular Biology, University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine of the USC, Los Angeles, USA
    J Natl Cancer Inst 93:1465-72. 2001
  9. ncbi Global and gene-specific epigenetic patterns in human bladder cancer genomes are relatively stable in vivo and in vitro over time
    I D Markl
    Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, Los Angeles, CA 90089, USA
    Cancer Res 61:5875-84. 2001
  10. ncbi Reduced rates of gene loss, gene silencing, and gene mutation in Dnmt1-deficient embryonic stem cells
    M F Chan
    Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, 90089-9176, USA
    Mol Cell Biol 21:7587-600. 2001

Collaborators

  • G Liang
  • P W Laird
  • M A Surani
  • J Sumegi
  • T T Nguyen
  • A H Wu
  • Mark Minden
  • F A Gonzales
  • K D Robertson
  • M Tsutsumi
  • C B Yoo
  • C T Nguyen
  • D Takai
  • C Nguyen
  • M F Chan
  • I D Markl
  • Z Xiong
  • M M Pao
  • D Shibata
  • E Uzvolgyi
  • M C Yu
  • J C Cheng
  • C Q Windham
  • J M Van Tornout
  • D Tsao-Wei
  • T Nijjar
  • J Cheng
  • E Cuppen
  • M J Thayer
  • J H Zhou
  • R K Ross
  • C M Bender
  • R van Amerongen
  • W F Benedict
  • C Blake
  • Y C Tsai
  • J L Tsao
  • S Groshen
  • P Eversole-Cire
  • C Talmadge
  • C H Spruck
  • C Schmutte
  • P T Chandrasoma
  • M Gonzalez-Zulueta
  • A Shibata
  • P W Nichols
  • A C Ferguson-Smith

Detail Information

Publications19

  1. ncbi The DNA methylation paradox
    P A Jones
    Department of Biochemistry and Molecular Biology, University of Southern, California Norris Comprehensive Cancer Center and Hospital, Los Angeles 90033 0800, USA
    Trends Genet 15:34-7. 1999
    ..The methylation paradox might be resolved if it is hypothesized that transcription through a CpG island facilitates de novo methylation...
  2. ncbi Cancer epigenetics comes of age
    P A Jones
    Department of Biochemistry and Molecular Biology, University of Southern California School of Medicine, The Norris Comprehensive Cancer Center, Los Angeles 90033, USA
    Nat Genet 21:163-7. 1999
    ..We review here current mechanistic understanding of the role of DNA methylation in malignant transformation, and suggest Knudson's two-hit hypothesis should now be expanded to include epigenetic mechanisms of gene inactivation...
  3. ncbi The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells
    M M Pao
    Department of Biochemistry and Molecular Biology, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA 90089-9176, USA
    Hum Mol Genet 10:903-10. 2001
    ....
  4. ncbi Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer
    D Takai
    Department of Biochemistry and Molecular Biology, USC Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, 1441 Eastlake Avenue, Los Angeles, CA 90033, USA
    Hum Mol Genet 10:2619-26. 2001
    ..Loss of methylation imprinting of H19 is linked to hypomethylation of the paternal allele in human bladder cancer, unlike the situation in Wilms' tumor and colon cancer where the maternal allele becomes hypermethylated...
  5. ncbi The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells
    G Liang
    Department of Biochemistry and Molecular Biology, University of Southern California Norris Comprehensive Cancer Center, School of Medicine, Los Angeles 90033, USA
    Cancer Res 60:4907-12. 2000
    ..Our results suggest that potential tumor suppressor genes can be isolated from human tumors by virtue of their altered methylation patterns...
  6. ncbi Expression of H19 does not influence the timing of replication of the Igf2/H19 imprinted region
    C Q Windham
    Department of Biochemistry and Molecular Biology, USC Norris Comprehensive Cancer Center, Los Angeles, USA
    Dev Genet 20:29-35. 1997
    ..This indicates that any differences in the timing of replication at the Igf2/H19 locus are of a lesser magnitude than those found in other imprinted regions...
  7. ncbi Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation
    C T Nguyen
    Department of Biochemistry and Molecular Biology, USC/Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, 1441 Eastlake Avenue, Room 8302L, Los Angeles, CA 90089-9181, USA
    Nucleic Acids Res 29:4598-606. 2001
    ....
  8. ncbi Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells
    C Nguyen
    Department of Biochemistry and Molecular Biology, University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine of the USC, Los Angeles, USA
    J Natl Cancer Inst 93:1465-72. 2001
    ..Subsequent selection of cells with a growth advantage conferred by spread of methylation into and inactivation of a particular promoter might then contribute to the genesis of a specific type of cancer...
  9. ncbi Global and gene-specific epigenetic patterns in human bladder cancer genomes are relatively stable in vivo and in vitro over time
    I D Markl
    Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, Los Angeles, CA 90089, USA
    Cancer Res 61:5875-84. 2001
    ....
  10. ncbi Reduced rates of gene loss, gene silencing, and gene mutation in Dnmt1-deficient embryonic stem cells
    M F Chan
    Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, 90089-9176, USA
    Mol Cell Biol 21:7587-600. 2001
    ..We conclude that Dnmt1 deficiency and the accompanying genomic DNA hypomethylation result in a reduction of three major pathways of gene inactivation in our model system...
  11. ncbi Presence of p53 mutations in primary nasopharyngeal carcinoma (NPC) in non-Asians of Los Angeles, California, a low-risk population for NPC
    J M Van Tornout
    Department of Pediatrics, JSC Norris Comprehensive Cancer Center, University of Southern California School of Medicine, Los Angeles 90033 0800, USA
    Cancer Epidemiol Biomarkers Prev 6:493-7. 1997
    ..This is the first report investigating the presence of p53 missense mutations in NPC among a low-risk population. Our data indicate that p53 is also an infrequent event among NPC patients at low risk for the disease...
  12. ncbi The role of DNA methylation in mammalian epigenetics
    P A Jones
    USC Norris Comprehensive Cancer Center, Departments of Biochemistry and Molecular Biology, Keck School of Medicine of the University of Southern California, 1441 Eastlake Avenue, MS 8302L, Los Angeles, CA 90089 9181, USA
    Science 293:1068-70. 2001
    ....
  13. ncbi Novel endothelin B receptor transcripts with the potential of generating a new receptor
    M Tsutsumi
    Department of Biochemistry and Molecular Biology, Urologic Cancer Research Laboratory USC Norris Comprehensive Cancer Center, University of Southern California, School of Medicine, Los Angeles, CA 90033, USA
    Gene 228:43-9. 1999
    ..These transcripts are widely expressed in human tissues, but their expression patterns vary between different tissues...
  14. ncbi Coordinate regulation of Igf-2 and H19 in cultured cells
    P Eversole-Cire
    Department of Biochemistry and Molecular Biology, USC Norris Comprehensive Cancer Center, University of Southern California, School of Medicine, Los Angeles 90033, USA
    Cell Growth Differ 6:337-45. 1995
    ..The data provide new experimental evidence for previously hypothesized mechanisms suggesting that Igf-2 and H19 are coordinately regulated...
  15. ncbi Mismatch repair deficiency and CpG island hypermethylation in sporadic colon adenocarcinomas
    Z Xiong
    Departments of Surgery, University of Southern California, Keck School of Medicine, Los Angeles, CA 90089-9176, USA
    Cancer Epidemiol Biomarkers Prev 10:799-803. 2001
    ....
  16. ncbi Multiple sites of interaction between the intracellular domains of an inwardly rectifying potassium channel, Kir6.2
    P A Jones
    University Laboratory of Physiology, Parks Road, Oxford OX1 3PT, UK
    FEBS Lett 508:85-9. 2001
    ....
  17. ncbi Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus
    K D Robertson
    USC Norris Comprehensive Cancer Center, Los Angeles, California 90033, USA
    Oncogene 18:3810-20. 1999
    ..The implications of the capacity of the INK4a/ARF locus to encode a third transcript, and for pancreatic cancer, in which the INK4a/ARF locus is nearly always altered, are considered...
  18. ncbi The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors
    K D Robertson
    University of Southern California, Norris Comprehensive Cancer Center, MS 83, 1441 Eastlake Avenue, Los Angeles, CA 90033, USA
    Nucleic Acids Res 27:2291-8. 1999
    ..Lastly, several novel alternatively spliced forms of DNMT3b, which may have altered enzymatic activity, were found to be expressed in a tissue-specific manner...
  19. ncbi Zebularine: a new drug for epigenetic therapy
    C B Yoo
    Department of Urology, USC/Norris Comprehensive Cancer Center, University of Southern California, Keck School of Medicine, 1441 Eastlake Ave, Los Angeles, CA 90089-9176, USA
    Biochem Soc Trans 32:910-2. 2004
    ..Further studies exploring the effectiveness of zebularine in a variety of settings could allow the development of novel therapies for cancer...